Rallybio acquires Avenzo therapeutics
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…
Company lists
Oncology, genomics, life science tools, neurology, medical devices and more: the companies building life sciences in Connecticut, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 333 life sciences companies in Connecticut, last 24 months: 31 M&A deals · 25 funding rounds · 6 Contracts · 4 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…
NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).
Total Specific Solutions has acquired Keypoint Intelligence, a provider of data, market intelligence, and analytical software for the global digital imaging industry.
Total Specific Solutions (“TSS”) has acquired Keypoint Intelligence, a leading US-based provider of data, market intelligence, and analytical software for the global digital imaging…
Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool AI March 31, 2026
Keypoint Intelligence has announced the launch of Keypoint Engage, a new set of AI-based execution services aimed at helping organizations achieve better results by executing industry…
Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrants Financing marks launch of Azitra new innovative…
Rallybio will acquire Candid through a merger transaction (the Merger).
Candid Therapeutics ... will continue development of its pipeline in the public markets by combining with Nasdaq-listed biotech Rallybio.
The firm’s affiliate print and imaging market research provider Keypoint Intelligence announced on Jan. 7 the acquisition of DataMaster Online.
This profile was developed just prior to the news of the proposed acquisition of Cegedim Relationship Management by IMS Health.
IMS Health, which has been fairly active over the past year in acquisitions, leading to its IPO in April , has announced the acquisition of parts of Cegedim, the Paris-based IT and…
Johnson & Johnson announced that it has entered into a definitive agreement to acquire Halda Therapeutics for $3.05B in cash.
Biohaven (NYSE:BHVN) has completed a $175 million public stock offering, using the fresh capital to shore up its balance sheet.
Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from Evonik Industries AG to market…
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral…
RoundTable has completed the sale of its minority stake in Designs for Health ("DFH" or the "Company") back to the Company.
Boutique fitness franchisor Xponential Fitness has divested from Lindora, the medical weight-loss and wellness chain it picked up last year, with Next Health, a fast-growing franchisor…
Deerfield Management Company, an investment firm dedicated to advancing healthcare, announced that it has closed on the sale of its portfolio company Melinta Therapeutics to CorMedix, Inc.
Treeline Biosciences, a secretive biotech startup co‑founded by Loxo Oncology’s Josh Bilenker and former Novartis oncology head Jeff Engelman, has emerged from stealth with $200 million…
FallCall Solutions, a Trumbull, CT–based SaaS-based life-safety technology company, has raised $1.5 million in a seed round.
In August 2025, CorMedix Inc. (NASDAQ:CRMD) announced the acquisition of Melinta Therapeutics, a commercial-stage company with seven marketed hospital- and clinic-focused infectious…
CorMedix CRMD will acquire Melinta Therapeutics, a New Jersey-based developer of antibiotics, from Deerfield Management for $300 million in cash and equity.
today announced the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies (Europe) B.V. (“IPA Europe”), to AVS Bio for a total enterprise value of $12 million USD.
Tudor Investment Corp ET AL purchased a new stake in Butterfly Network during the 4th quarter worth about $2,761,000.
Raymond James Financial Inc. purchased a new stake in Butterfly Network during the 4th quarter worth about $3,154,000.
Jefferies Financial Group Inc. acquired a new stake in Butterfly Network, Inc. (NYSE:BFLY – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor…
First Light Asset Management LLC acquired a new stake in shares of Butterfly Network during the fourth quarter worth $12,463,000.
Capital World Investors purchased a new stake in Butterfly Network during the 4th quarter worth about $4,239,000.
Parkman Healthcare Partners LLC purchased a new stake in Butterfly Network in the 4th quarter valued at about $2,340,000.
Few life sciences companies in Connecticut publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 231 active companies.

Developer of transformative precision medicines to treat cancer
OncologyUS$1.10bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D417/14, A61P35/00, C07D491/107Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of clinician-controlled at-home physical therapy devices
Healthcare itUS$532.81m across 12 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Portable ultrasound system for external ultrasound imaging
Imaging diagnosticsUS$350.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Handheld portable ultrasound imaging with microfabricated transducers and automated data handling
CPC B06B1/0292, A61B8/4483, A61B8/5207Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of precision therapies for autoimmune and inflammatory disease conditions
ImmunologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of genome-based diagnostic testing solutions for reproductive health and oncology
GenomicsUS$241.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibodies & protein therapies for rare disorders
Rare diseasesUS$182.20m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of next-generation immuno-oncology-based drugs
ImmunotherapyUS$175.43m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Novel immune‑checkpoint antibody therapeutics for cancer immunotherapy.
CPC C07K16/2803, A61K39/3955, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of expandable and less invasive surgical spinal medical devices
OrthopedicsUS$136.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Spinal interbody fusion implants and modular tensioned fixation screws for vertebral stabilization
CPC A61F2/4455, A61F2/447, A61F2/4611Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics that target the tumour microenvironment
OncologyUS$118.07m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule drugs to target and degrade disease causing proteins
OncologyUS$100.12m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted protein degradation (PROTAC) therapeutics for hormone receptors and other disease proteins
CPC C07D401/14, C07D417/14, A61K45/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a non-invasive test to detect health conditions through the eyes
OphthalmologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics with anti-tumor effect
OncologyUS$76.51m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a molecular diagnostics platform
Infectious diseasesUS$44.55m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
GenomicsUS$37.40m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered live microbial therapeutics for dermatological disease treatment
CPC A61K35/74, C12N15/74, C12N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Synthetic products for soft tissue regeneration of anterior cruciate ligament injuries
OrthopedicsUS$37.28m across 13 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing immunotherapeutics to restore neural connections in neurodegenerative diseases
NeurologyUS$33.87m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI-powered platform to accelerate investigational new drug submission
Generative aiUS$31.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of dietary supplements
Food & beverage productsUS$27.24m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Heat‑moisture‑treated carbohydrate excipients for pharmaceutical formulations
CPC A61K36/899Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a therapeutic device to treat patients with heart failure
Cardiac and vascular disordersUS$28.10m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Medical device company specializing in epicardial access systems for minimally invasive procedures
Cardiac and vascular disordersUS$24.18m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision therapeutics targeting microbial-driven diseases
ImmunologyUS$23.62m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of whole-brain perfusion model for drug discovery
Life sciences techFocus: Advanced organ perfusion systems and AI-driven brain perfusion modeling for medical therapies
CPC A01N1/143, G06N5/02, A61M1/3613Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of biotextile for enhanced screw fixation
OrthopedicsUS$22.12m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Unleashing online potential through domain services and website optimization
DiabetesEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Reformulating oncology drugs for treating late stage solid tumors
OncologyUS$20.98m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a noninvasive vision correction treatment
OphthalmologyUS$19.94m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61F9/0079, A61N5/062, A61F9/008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Point of care diagnostic test for preeclampsia
Disease self managementUS$17.21m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Diagnostic devices for detecting misfolded proteins in biomedical samples
CPC G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of drugs related to oncology, autoimmune, and cardiovascular
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of genomic and gene editing platforms for crop improvement
Crop techUS$15.03m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Company developing first-in-class drugs to treat injuries and damages to the CNS
NeurologyUS$13.42m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of cell therapies for cancer treatment
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of healthcare education and clinical trial solutions for patients and professionals
Life sciences techUS$12.53m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Online platform offering personalized nutrition plans for payers and individuals
Fitness & wellness techUS$11.37m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a molecular diagnostic testing tool for endometriosis in women
GenomicsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of an analgesic product candidate and polymer and hydrogel drug delivery platform technologies
NeurologyUS$8.85m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a platform for the analysis of proteomics
Life sciences platforms and toolsUS$8.60m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Multiplexed microfluidic platforms for simultaneous biomarker capture and analysis
CPC G01N33/543, B01J19/0046Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing oral treatments for cancer and inflammatory lung diseases
OncologyUS$7.66m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Pipe end flare sealing devices and adjustable electrical enclosure mounting solutions
CPC H02G3/126, B29C57/04, F16L13/02Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a protein-based retinal prosthesis for retinal degenerative diseases
OphthalmologyUS$7.65m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Retinal cell stimulation therapies for vision restoration
CPC A61F2/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of treatments for chemotherapy-induced peripheral neuropathy (CIPN)
OncologyUS$7.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of cell therapy development platform services
Life sciences platforms and toolsUS$7.47m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

miRNA-based diagnostic tests
GenomicsUS$7.16m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive cancer biomarkers for immunotherapy response and radiation toxicity assessment.
CPC G02B27/0172, C12Q1/6886, G06F3/012Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of nutritional supplements to improve health
Nutraceuticals techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI platform to authenticate medicines & a platform to enable pharmacy procurement
Pharmacy itUS$5.35m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of photodynamic therapy device for treating lung cancer
PulmonologyUS$5.34m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Provides advanced optical delivery systems for photodynamic cancer therapy and imaging
CPC A61N5/062, A61B5/0071, A61N5/0601Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a portable nebulizer for asthma and COPD
PulmonologyUS$4.61m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of sequencing technology for microbiome testing, pathogen identification, and tracking
Life sciences platforms and toolsUS$4.14m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of optical based guided surgical tools for cancer surgery
OncologyFocus: Intraoperative fluorescence, Raman, and multispectral imaging for cancer margin detection
CPC G01N21/65, G01N21/658, G01N21/6456Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Delicious, grass-fed yogurt crafted with love, less sugar, and more probiotics
Nutraceuticals techUS$2.87m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of medical equipment support services
Hospital equipmentEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Connecticut on RadarBrowse life sciences companies in Connecticut working on oncology, genomics, diagnostics, and medical devices. Find life sciences startups in Connecticut and companies hiring in the sector.
Life sciences companies developing cancer diagnostics and therapies.

Developer of transformative precision medicines to treat cancer
Oncology
Developer of next-generation immuno-oncology-based drugs
Immunotherapy
Developer of therapeutics that target the tumour microenvironment
Oncology
Developer of small molecule drugs to target and degrade disease causing proteins
Oncology
Developer of therapeutics with anti-tumor effect
OncologyCompanies developing genomic testing, sequencing, and precision medicine tools.

Provider of genome-based diagnostic testing solutions for reproductive health and oncology
GenomicsDeveloper of a molecular diagnostics platform
Infectious diseases
Developer of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
Genomics
Developer of genomic and gene editing platforms for crop improvement
Crop tech
Provider of a molecular diagnostic testing tool for endometriosis in women
GenomicsCompanies providing laboratory platforms, instruments, and research tools.

AI-powered platform to accelerate investigational new drug submission
Generative ai
Developer of whole-brain perfusion model for drug discovery
Life sciences tech
Provider of healthcare education and clinical trial solutions for patients and professionals
Life sciences tech
Provider of a platform for the analysis of proteomics
Life sciences platforms and tools
Provider of cell therapy development platform services
Life sciences platforms and toolsCompanies developing neurological therapies, devices, and pain treatments.

Developing immunotherapeutics to restore neural connections in neurodegenerative diseases
NeurologyProvider of an analgesic product candidate and polymer and hydrogel drug delivery platform technologies
Neurology
Innovative pain relief solutions using neurostimulation technology for athletes and chronic pain sufferers
Neurology
Developer of diagnostic tests for Parkinson’s disease and related conditions
Neurology
Developer of therapeutics for the treatment of CNS and oncology
NeurologyCompanies building diagnostic equipment, therapeutic devices, and clinical tools.

Developer of a therapeutic device to treat patients with heart failure
Cardiac and vascular disorders
Medical device company specializing in epicardial access systems for minimally invasive procedures
Cardiac and vascular disorders
Developer of photodynamic therapy device for treating lung cancer
Pulmonology
Developer of a portable nebulizer for asthma and COPD
Pulmonology
Provider of medical equipment support services
Hospital equipmentRecently founded life sciences companies in Connecticut.

Developer of transformative precision medicines to treat cancer
OncologyDeveloper of precision therapies for autoimmune and inflammatory disease conditions
Immunology
AI-powered platform to accelerate investigational new drug submission
Generative ai
Developer of whole-brain perfusion model for drug discovery
Life sciences tech
Developer of cell therapies for cancer treatment
OncologyLife sciences companies in Connecticut with hiring activity.

Developer of transformative precision medicines to treat cancer
Oncology
Provider of clinician-controlled at-home physical therapy devices
Healthcare it
Portable ultrasound system for external ultrasound imaging
Imaging diagnostics
Developer of next-generation immuno-oncology-based drugs
Immunotherapy
Developer of small molecule drugs to target and degrade disease causing proteins
OncologyLife sciences companies in Connecticut listed on public markets.

Portable ultrasound system for external ultrasound imaging
Imaging diagnostics
Provider of genome-based diagnostic testing solutions for reproductive health and oncology
Genomics
Developer of antibodies & protein therapies for rare disorders
Rare diseases
Developer of next-generation immuno-oncology-based drugs
Immunotherapy
Developer of small molecule drugs to target and degrade disease causing proteins
OncologyThe most-installed Android apps published by life sciences companies headquartered in Connecticut — 76K installs between them. 5 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Connecticut compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 333 life sciences companies in Connecticut among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of Connecticut maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
76 life sciences companies in Connecticut have recorded equity funding, US$4.01bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
OncologyDeveloper of transformative precision medicines to treat cancer
Healthcare itProvider of clinician-controlled at-home physical therapy devices
Imaging diagnosticsPortable ultrasound system for external ultrasound imaging
Developer of precision therapies for autoimmune and inflammatory disease conditions
Founders
Details not available
GenomicsProvider of genome-based diagnostic testing solutions for reproductive health and oncology
Rare diseasesDeveloper of antibodies & protein therapies for rare disorders
ImmunotherapyDeveloper of next-generation immuno-oncology-based drugs
OrthopedicsManufacturer of expandable and less invasive surgical spinal medical devices
OncologyDeveloper of therapeutics that target the tumour microenvironment
OncologyDeveloper of small molecule drugs to target and degrade disease causing proteins
OphthalmologyDeveloper of a non-invasive test to detect health conditions through the eyes
OncologyDeveloper of therapeutics with anti-tumor effect
Developer of a molecular diagnostics platform
GenomicsDeveloper of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
OrthopedicsSynthetic products for soft tissue regeneration of anterior cruciate ligament injuries
NeurologyDeveloping immunotherapeutics to restore neural connections in neurodegenerative diseases
US$1.10bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D417/14, A61P35/00, C07D491/107Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$532.81m across 12 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$350.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Handheld portable ultrasound imaging with microfabricated transducers and automated data handling
CPC B06B1/0292, A61B8/4483, A61B8/5207Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$241.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$182.20m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$175.43m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Novel immune‑checkpoint antibody therapeutics for cancer immunotherapy.
CPC C07K16/2803, A61K39/3955, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$136.40m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Spinal interbody fusion implants and modular tensioned fixation screws for vertebral stabilization
CPC A61F2/4455, A61F2/447, A61F2/4611Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$118.07m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$100.12m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted protein degradation (PROTAC) therapeutics for hormone receptors and other disease proteins
CPC C07D401/14, C07D417/14, A61K45/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$76.51m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$44.55m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$37.40m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered live microbial therapeutics for dermatological disease treatment
CPC A61K35/74, C12N15/74, C12N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$37.28m across 13 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$33.87m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Connecticut. 157 of 231 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Hospital equipmentDeveloper of smart devices for hospitals
OncologyDeveloper of therapeutics with anti-tumor effect
NanotechnologyTargeted antiviral therapeutics
DiabetesUnleashing online potential through domain services and website optimization
NeurologyDeveloper of therapies to treat cancer, pain, and CNS disorders
OrthopedicsSurgical positioning devices and patient protection solutions improving surgical efficiency
Nutraceuticals techManufacturer of flavors, fragrances & botanical extracts
GenomicsMolecular Diagnostics in cardiology, oncology, and inherited diseases
Founders
Details not available
Fitness & wellness techOnline platform offering personalized nutrition plans for payers and individuals
Pharmacy itAI platform to authenticate medicines & a platform to enable pharmacy procurement
Life sciences techProvider of software solutions for stability assessment
Developer of an artificial intelligence platform for drug discovery and development
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$76.51m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Enrichment and detection of low-frequency DNA variants using cold-PCR for diagnostic sequencing
CPC C12N9/22, C12Q1/6858, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.37m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.35m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Pharmaceutical compositions and methods for treating inflammatory and gastrointestinal diseases
CPC A61K31/4178, C07D401/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Connecticut with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
OncologyManufacturer of microfluidic-based tumour on chip technology
Imaging diagnosticsPortable ultrasound system for external ultrasound imaging
Life sciences techProvider of healthcare education and clinical trial solutions for patients and professionals
Fitness & wellness techOnline platform offering personalized nutrition plans for payers and individuals
Food & beverage productsManufacturer of dietary supplements
GenomicsDigital genetic counseling platform bridging genetics and precision medicine
Diversified pharmaceuticalsPioneering stem cell technology for transformative medicines in autoimmune and rare diseases
GenomicsmiRNA-based diagnostic tests
GenomicsProvider of a molecular diagnostic testing tool for endometriosis in women
Life sciences platforms and toolsDeveloper of technology for the synthesis of nanoparticles
OrthopedicsDeveloper of biotextile for enhanced screw fixation
Disease self managementProvider of non-invasive home device for strengthening pelvic muscles control
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$350.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Handheld portable ultrasound imaging with microfabricated transducers and automated data handling
CPC B06B1/0292, A61B8/4483, A61B8/5207Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.53m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$11.37m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$27.24m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Heat‑moisture‑treated carbohydrate excipients for pharmaceutical formulations
CPC A61K36/899Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.36m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.16m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive cancer biomarkers for immunotherapy response and radiation toxicity assessment.
CPC G02B27/0172, C12Q1/6886, G06F3/012Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$22.12m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Electrical stimulation devices for urinary incontinence therapy
CPC A61N1/36007, A61N1/0452Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Connecticut founded in the last four years, newest first.
Developer of precision therapies for autoimmune and inflammatory disease conditions
Founders
Details not available
NeurologyDeveloper of short-acting, rapid-onset DMT-based treatments for treatment-resistant depression
Life sciences platforms and toolsProvider of reverse transcriptase solutions for RNA analysis
Life sciences techAI-powered computational platform for drug design
Gene therapyDeveloper of RNA-based therapeutics for cancer treatment
Founders
Details not available
NeurologyDeveloper of an electrotherapy device for the treatment of pain and anxiety
Founders
Details not available
Drug deliveryDeveloper of a transdermal patch for vaccine delivery
Life sciences platforms and toolsProvider of cell therapy development platform services
Generative aiAI-powered platform to accelerate investigational new drug submission
NeurologyDeveloper of diagnostic tests for Parkinson’s disease and related conditions
Founders
Details not available
Diversified pharmaceuticalsDeveloper of radiopharmaceuticals for the treatment of neurological and neuropsychiatric diseases
Founders
Details not available
Life sciences techDeveloper of nanophotonic platforms for detecting and isolating rare cells
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.47m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$31.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microfluidic devices for high‑throughput cellular and biomolecular analysis
CPC G01N21/4788, G01N15/01Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Imaging diagnosticsPortable ultrasound system for external ultrasound imaging
OncologyDeveloper of non-invasive diagnostic tests for cancer detection
OncologyDeveloper of small molecule drugs to target and degrade disease causing proteins
Diversified pharmaceuticalsDeveloper of radiopharmaceuticals for the treatment of neurological and neuropsychiatric diseases
Founders
Details not available
GenomicsDeveloper of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
ImmunotherapyDeveloper of next-generation immuno-oncology-based drugs
Rare diseasesDeveloper of antibodies & protein therapies for rare disorders
GenomicsMolecular Diagnostics in cardiology, oncology, and inherited diseases
Founders
Details not available
NanotechnologyTargeted antiviral therapeutics
Generative aiAI-powered platform to accelerate investigational new drug submission
OrthopedicsCustom prosthetics using CAD technology
DiabetesUnleashing online potential through domain services and website optimization
US$350.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Handheld portable ultrasound imaging with microfabricated transducers and automated data handling
CPC B06B1/0292, A61B8/4483, A61B8/5207Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$35.24m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Automated fluorescence imaging and digital pathology for cancer detection and specimen analysis
CPC G02B21/34, C12Q1/6841, G02B21/24Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$100.12m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted protein degradation (PROTAC) therapeutics for hormone receptors and other disease proteins
CPC C07D401/14, C07D417/14, A61K45/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$37.40m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered live microbial therapeutics for dermatological disease treatment
CPC A61K35/74, C12N15/74, C12N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$175.43m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Novel immune‑checkpoint antibody therapeutics for cancer immunotherapy.
CPC C07K16/2803, A61K39/3955, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$182.20m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Enrichment and detection of low-frequency DNA variants using cold-PCR for diagnostic sequencing
CPC C12N9/22, C12Q1/6858, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$31.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Connecticut. Open a company to see what it sells, who runs it and how far it has come.
31 life sciences companies in Connecticut work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of healthcare education and clinical trial solutions for patients and professionals
Pharmacy itAI platform to authenticate medicines & a platform to enable pharmacy procurement
Life sciences techProvider of omics data analysis platform
Founders
Details not available
Generative aiAI-powered platform to accelerate investigational new drug submission
Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors
Life sciences techDeveloper of whole-brain perfusion model for drug discovery
Life sciences techOpinion leader management and investigator sponsored trial solutions
SaasKeypoint Intelligence is a one-stop shop for the digital imaging industry.
Founders
Details not available
Life sciences techAI-powered drug discovery and development for transformative medicines
Life sciences techProvider of software solutions for stability assessment
Developer of an artificial intelligence platform for drug discovery and development
Founders
Details not available
Life sciences techElectronic document management and quality management software
Founders
Details not available
US$12.53m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.35m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microfluidic chiplet platforms enabling high‑throughput, spatially encoded tissue assay screening
CPC B01L3/502707, C12Q1/6841, C12Q1/6832Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$31.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Advanced organ perfusion systems and AI-driven brain perfusion modeling for medical therapies
CPC A01N1/143, G06N5/02, A61M1/3613Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Therapeutic small‑molecule drugs targeting inflammation, cancer, and ubiquitin‑proteasome/kinase pathways
CPC A61K31/4174, A61K38/05, G16H10/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Pharmaceutical compositions and methods for treating inflammatory and gastrointestinal diseases
CPC A61K31/4178, C07D401/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
29 life sciences companies in Connecticut work in oncology. Shown: the best-documented.
OncologyManufacturer of microfluidic-based tumour on chip technology
OncologyDeveloper of small molecule drugs to target and degrade disease causing proteins
OncologyDeveloper of transformative precision medicines to treat cancer
ImmunotherapyDeveloper of next-generation immuno-oncology-based drugs
OncologyDeveloper of optical based guided surgical tools for cancer surgery
OncologyDeveloper of therapeutics that target the tumour microenvironment
GenomicsDeveloper of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
OncologyDeveloper of therapeutics with anti-tumor effect
GenomicsmiRNA-based diagnostic tests
GenomicsProvider of a molecular diagnostic testing tool for endometriosis in women
PulmonologyDeveloper of photodynamic therapy device for treating lung cancer
OncologyDeveloper of cell therapies for cancer treatment
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$100.12m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted protein degradation (PROTAC) therapeutics for hormone receptors and other disease proteins
CPC C07D401/14, C07D417/14, A61K45/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.10bn across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D417/14, A61P35/00, C07D491/107Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$175.43m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Novel immune‑checkpoint antibody therapeutics for cancer immunotherapy.
CPC C07K16/2803, A61K39/3955, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Intraoperative fluorescence, Raman, and multispectral imaging for cancer margin detection
CPC G01N21/65, G01N21/658, G01N21/6456Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$118.07m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$37.40m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered live microbial therapeutics for dermatological disease treatment
CPC A61K35/74, C12N15/74, C12N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$76.51m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.16m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive cancer biomarkers for immunotherapy response and radiation toxicity assessment.
CPC G02B27/0172, C12Q1/6886, G06F3/012Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.34m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Provides advanced optical delivery systems for photodynamic cancer therapy and imaging
CPC A61N5/062, A61B5/0071, A61N5/0601Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
27 life sciences companies in Connecticut work in life sciences platforms and tools. Shown: the best-documented.
GenomicsDigital genetic counseling platform bridging genetics and precision medicine
Life sciences platforms and toolsProvider of cell therapy development platform services
Life sciences platforms and toolsDeveloper of technology for the synthesis of nanoparticles
GenomicsDeveloper of instruments for the detection of rare cells in the blood circulation
Life sciences platforms and toolsDeveloper of sequencing technology for microbiome testing, pathogen identification, and tracking
Life sciences platforms and toolsProvider of a platform for the analysis of proteomics
Life sciences platforms and toolsDeveloper of NK cell culture media for cell therapies
Life sciences platforms and toolsDietary supplements and medical foods for health care professionals and patients
Life sciences platforms and toolsAVS bio produces Specific Pathogen Free (SPF) eggs and adjacent laboratory products and services for the development of biologics.
Founders
Details not available
Life sciences platforms and toolsDeveloper of technology to produce engineered heart tissues for research and drug discovery
Founders
Details not available
OncologyNon-invasive diagnostic tests for cancer
Founders
Details not available
Life sciences platforms and toolsArome Science provides data acquisition, sample preparation, and R&D consulting services.
Founders
Details not available
US$1.36m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.47m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.83m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy diagnostics: detecting circulating tumor cells, viral pathogens, and biomarkers in biological samples.
CPC G01N33/582, B01L9/065, G01N33/5759Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.14m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.60m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Multiplexed microfluidic platforms for simultaneous biomarker capture and analysis
CPC G01N33/543, B01J19/0046Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: In vitro tissue engineering platforms for generating and testing engineered biological tissues.
CPC C12M21/08, C12M23/42Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
27 life sciences companies in Connecticut work in genomics. Shown: the best-documented.
GenomicsProvider of genome-based diagnostic testing solutions for reproductive health and oncology
GenomicsDigital genetic counseling platform bridging genetics and precision medicine
Life sciences techProvider of omics data analysis platform
Founders
Details not available
GenomicsDeveloper of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema
Life sciences platforms and toolsProvider of cell therapy development platform services
Crop techDeveloper of genomic and gene editing platforms for crop improvement
GenomicsmiRNA-based diagnostic tests
GenomicsProvider of a molecular diagnostic testing tool for endometriosis in women
Developer of a molecular diagnostics platform
GenomicsDeveloper of instruments for the detection of rare cells in the blood circulation
Life sciences platforms and toolsDeveloper of sequencing technology for microbiome testing, pathogen identification, and tracking
GenomicsDeveloper of proprietary microbiome technology
US$241.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.36m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Microfluidic chiplet platforms enabling high‑throughput, spatially encoded tissue assay screening
CPC B01L3/502707, C12Q1/6841, C12Q1/6832Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$37.40m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered live microbial therapeutics for dermatological disease treatment
CPC A61K35/74, C12N15/74, C12N1/205Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.47m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.03m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$7.16m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Predictive cancer biomarkers for immunotherapy response and radiation toxicity assessment.
CPC G02B27/0172, C12Q1/6886, G06F3/012Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$44.55m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.83m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Liquid biopsy diagnostics: detecting circulating tumor cells, viral pathogens, and biomarkers in biological samples.
CPC G01N33/582, B01L9/065, G01N33/5759Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.14m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.76m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Veterinary feed additives and metabolic therapeutics improving poultry safety and efficiency.
CPC A61K35/74, A61K35/741, A23K10/18Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
100 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.